|
1）Parise H, Maehara A, Stone GW, et al. Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. Am J Cardiol. 2011; 107: 374-82
|
|
|
|
2）Chieffo A, Latib A, Caussin C, et al. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J. 2013; 165: 65-72
|
|
|
|
|
|
3）Kim JS, Kang TS, Mintz GS, et al. Randomized comparison of clinical outcomes between intravascular ultrasound and angiography-guided drug-eluting stent implantation for long coronary artery stenoses. JACC Cardiovasc Interv. 2013; 6: 369-76
|
|
|
|
|
|
4）Claessen BE, Mehran R, Mintz GS, et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC Cardiovasc Interv. 2011; 4: 974-81
|
|
|
|
|
|
5）Park KW, Kang SH, Yang HM, et al. Impact of intravascular ultrasound guidance in routine percutaneous coronary intervention for conventional lesions: data from the EXCELLENT trial. Int J Cardiol. 2013; 167: 721-6
|
|
|
|
|
|
6）Takarada S, Imanishi T, Liu Y, et al. Cardiovasc Interv 75: 202-6,2010 Advantage of next-generation frequency-domain optical coherence tomo-graphy compared with conventional time-domain system in the assessment of coronary lesion. Cardiovasc Interv. 2010; 75: 202-6
|
|
|
|
|
|
7）Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultra-sound and coronary angioscopy. J Am Coll Cardiol. 2007; 50: 933-9
|
|
|
|
|
|
8）Maehara A, Mintz GS, Castagna MT, et al. Intravascular ultrasound assessment of spontaneous coronary artery dissection. Am J Cardiol. 2002; 89: 466-8
|
|
|
|
|
|
9）Alfonso F, Paulo M, Dutary J. Endovascular imaging of angiographically invisible spontaneous coronary artery dissection. JACC Cardiovasc Interv. 2012; 5: 452-3
|
|
|
|
|
|
10）Paulo M, Sandoval J, Lennie V, et al. Combined use of OCT and IVUS in spontaneous coronary artery dissection. JACC Cardiovasc Imaging. 2013; 6: 830-2
|
|
|
|
|
|
11）Cordone S, Ghione M, Foin N, et al. Endovascular imaging and 3-dimensional reconstruction of spontaneous coronary artery dissection. J Am Coll Cardiol. 2013; 62: 350
|
|
|
|
|
|
12）Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003; 107: 2900-7
|
|
|
|
|
|
13）De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012; 367: 991-1001
|
|
|
|
|
|
14）Cavallini C, Savonitto S, Violini R, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality afterpercutaneous coronary intervention: results of theCK-MB and PCI study. Eur Heart J. 2005; 26: 1494-8
|
|
|
|
|
|
15）Ellis SG, Chew D, Chan A, et al. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation. 2002; 106: 1205-10
|
|
|
|
|
|
16）Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med. 2011; 364: 453-64
|
|
|
|
|
|
17）Uetani T, Amano T, Ando H, et al. The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation. Eur Heart J. 2008; 29: 1714-20
|
|
|
|
|
|
18）Arai K, Ishii H, Amano T, et al. Volumetric analysis of coronary plaque characterization in patients with metabolic syndrome using 64-slice multi-detector computed tomography. Circ J. 2010; 74: 2146-51
|
|
|
|
|
19）Uetani T, Amano T, Kunimura A, et al. The association between plaque characterization by CT angiography and post-procedural myocardial infarction in patients with elective stent implantation. JACC Cardiovasc Imaging. 2010; 3: 19-28
|
|
|
|
|
|
20）Lee T, Yonetsu T, Koura K, et al. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation. Circ Cardiovasc Interv. 2011; 4: 378-86
|
|
|
|
|
|
21）Fujii K, Kawasaki D, Oka K, et al. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2011; 4: 513-20
|
|
|
|
|
|
22）Amano T, Matsubara T, Uetani T, et al. Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: an integrated backscatter intravascular ultrasound study. Atherosclerosis. 2011; 218: 110-6
|
|
|
|
|
|
23）Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349: 1314-23
|
|
|
|
|
|
24）Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004; 350: 221-31
|
|
|
|
|
|
25）Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol. 2004; 43: 1959-63
|
|
|
|
|
|
26）Moses JW, Dangas G, Mehran R, et al. Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome. Am J Cardiol. 2008; 102: 24-8
|
|
|
|
|
|
27）Gerber RT, Latib A, Ielasi A, et al. Defining a new standard for IVUS optimized drug eluting stent implantation: the PRAVIO study. Catheter Cardiovasc Interv. 2009; 74: 348-56
|
|
|
|
|
|
28）Ando H, Amano T, Takashima H, et al. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis. Eur Heart J Cardiovasc Imaging. 2013; 14: 996-1001
|
|
|
|
|
|
29）Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011; 57: 1314-22
|
|
|
|
|
|
30）Kang SJ, Mintz GS, Akasaka T, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation. 2011; 123: 2954-63
|
|
|
|
|
|
31）Ando H, Ishii H, Yoshikawa D, et al. Disruption of atherosclerotic neointima as a cause of very late stent thrombosis after bare metal stent implantation. Am J Cardiol. 2012; 109: 448-9
|
|
|
|
|
|
32）Cook S, Eshtehardi P, Kalesan B, et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. Eur Heart J. 2012; 33: 1334-43
|
|
|
|
|
|
33）Amano T, Matsubara T, Uetani T, et al. Lipid-rich plaques predict non-target-lesion ischemic events in patients undergoing percutaneous coronary intervention. Circ J. 2011; 75: 157-66
|
|
|
|
|
|
34）Amano T, Matsubara T, Uetani T, et al. Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions: integrated backscatter intravascular ultrasound study. J Am Coll Cardiol. 2007; 49: 1149-56
|
|
|
|
|
|
35）Amano T, Matsubara T, Uetani T, et al. Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. JACC Cardiovasc Interv. 2008; 1: 39-45
|
|
|
|
|
|
36）Kawasaki M, Sano K, Okubo M, et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol. 2005; 45: 1946-53
|
|
|
|
|
|
37）Uetani T, Amano T, Kumagai S, et al. Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents. JACC Cardiovasc Interv. 2012; 5: 1159-67
|
|
|
|
|
|
38）Ogasawara D, Shite J, Shinke T, et al. Pioglitazone reduces the necrotic-core component in coronary plaque in association with enhanced plasma adiponectin in patients with type 2 diabetes mellitus. Circ J. 2009; 73: 343-51
|
|
|
|
|